Eledon Pharmaceuticals, Inc. fell 11.4% on Thursday, November 12, 2026, on 810,300 shares. The headline around the move:
Eledon Pharmaceuticals, Inc. (ELDN:NASDAQ) closed at $2.12 on November 13, 2026, down 10.57% on the day. The stock trades 52.9% below its 52-week high of $4.49 and 56.7% above its 52-week low of $1.35. Over the past year, it gained 20.2%. Eledon Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, ELDN closed higher on 117 days (46%). Its best day was October 28, 2026 (+14.52%) and its worst was November 12, 2026 (-11.42%). The stock moved 10% or more in a single session 12 times.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.
Find more stocks like ELDN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.